WallStreetZenWallStreetZen

NASDAQ: NGNE
Neurogene Inc Stock Ownership - Who owns Neurogene?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurogene Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christine Mikail CvijicPresident and CFO2025-03-134,501$16.94
$76.25kSell
Samsara Biocapital GP LLC10% Owner2024-11-262,000$27.50
$55.00kBuy
Samsara Biocapital GP LLC10% Owner2024-11-2610,803$26.01
$280.99kBuy
Samsara Biocapital GP LLC10% Owner2024-11-2620,748$24.91
$516.83kBuy
Samsara Biocapital GP LLC10% Owner2024-11-2615,219$26.73
$406.80kBuy
Rachel McMinnChief Executive Officer2024-11-2247,500$20.40
$969.00kBuy
Christine Mikail CvijicPresident and CFO2024-11-2224,000$20.48
$491.40kBuy

1 of 1

NGNE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NGNE insiders and whales buy or sell their stock.

NGNE Shareholders

What type of owners hold Neurogene Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC25.90%3,866,579$50.38MInsider
Jonathan G. Drachman15.40%2,298,686$29.95MInsider
Gary Bridger12.88%1,922,775$25.05MInsider
Samsara Biocapital LLC11.50%1,717,127$22.37MInstitution
Samsara Biocapital GP LLC11.17%1,668,357$21.74MInsider
Ventures West 8 Limited Partnership10.34%1,543,989$20.12MInsider
Blackrock Inc10.16%1,516,157$19.76MInstitution
Johnson Johnson9.66%1,442,094$18.79MInsider
Carl Walkey9.06%1,352,489$17.62MInsider
Rtw Investments LP9.04%1,350,256$17.59MInstitution

1 of 3

NGNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGNE47.44%52.56%Net BuyingNet Selling
HUMA27.13%22.31%Net SellingNet Buying
ALMS69.03%30.97%Net BuyingNet Buying
PRME38.69%61.31%
RZLT29.06%70.94%Net BuyingNet Buying
View Top Biotech Stocks

Neurogene Stock Ownership FAQ

Who owns Neurogene?

Neurogene (NASDAQ: NGNE) is owned by 107.77% institutional shareholders, 119.41% Neurogene insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Neurogene shareholder, owning 3.87M shares representing 25.90% of the company. Redmile Group LLC's Neurogene shares are currently valued at $58.00M.

If you're new to stock investing, here's how to buy Neurogene stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.